Oncologic Risk Stratification Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Carcinomatosis.

Autor: Wagner PL; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Austin F; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Zenati M; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Jaech A; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Mavanur A; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Ramalingam L; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Jones HL; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Holtzman MP; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Ahrendt SA; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Zureikat AH; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Pingpank JF; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Zeh HJ; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Bartlett DL; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Choudry HA; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. choudrymh@upmc.edu.
Jazyk: angličtina
Zdroj: Annals of surgical oncology [Ann Surg Oncol] 2016 May; Vol. 23 (5), pp. 1587-93. Date of Electronic Publication: 2016 Jan 07.
DOI: 10.1245/s10434-015-5037-7
Abstrakt: Introduction: Patients with peritoneal carcinomatosis (PC) of appendiceal origin demonstrate variable oncologic outcomes, despite aggressive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). We sought to devise a prognostic risk stratification system for oncologic outcomes following CRS-HIPEC.
Methods: A total of 197 patients undergoing CRS-HIPEC for the treatment of appendiceal PC were reviewed from a prospective database. Kaplan-Meier survival curves and multivariate Cox regression models were used to identify prognostic factors affecting oncologic outcomes. Clinicopathologic variables affecting overall survival (OS) were utilized to develop a prognostic staging system and nomograms.
Results: Univariate and multivariate Cox regression analysis indicated that high-grade tumor histology, lymph node metastasis, and incomplete cytoreduction were high-risk features, adversely affecting OS. Patients were stratified on the presence of high-risk features as follows: low-risk patients had no risk factors (n = 102); intermediate-risk patients had one risk factor (n = 49); and high-risk patients had more than one risk factor (n = 46). Median OS for low-risk patients was not reached, and was 43 and 22 months for intermediate-risk and high-risk patients, respectively. Five-year OS was 72, 43, and 13 % for low-, intermediate- and high-risk patients, respectively (p < 0.0003 for low vs. intermediate risk, and p = 0.06 for intermediate vs. high risk).
Conclusions: We propose a three-tier staging system for appendiceal PC following CRS-HIPEC, based on histologic grade, lymph node involvement, and completeness of cytoreduction. The presence of any one or more of these high-risk features significantly decreased survival in our single-institution database and provided the basis for a prognostic staging system and corresponding nomograms.
Databáze: MEDLINE
Externí odkaz: